Affymetrix plans to introduce genotyping product in early 2007

By Elaine Rigoli

Tampa, Fla., July 18 - Affymetrix, Inc. said it plans to introduce a 1 million-SNP (single nucleotide polymorphisms) product by the first quarter of 2007 and that the U.S. list price of its current two-chip 500K SNP genotyping set will be reduced to $250, effective immediately.

Additionally, the 500K set will be offered as a single array by the end of the year, increasing throughput and enabling scientists to devote their resources toward performing larger experiments, the company said in a news release.

The company said the reduced price of the Affymetrix 500K array will enable scientists to run more samples, and thereby increase the power of their genetic association studies.

"Our business strategy over the past decade has been to use our manufacturing leverage and technical innovations to give customers more data per dollar each passing year. That strategy was instrumental in growing the gene expression market and we believe that reducing the price per SNP will significantly increase the overall genotyping market opportunity, particularly where large sample populations are required," founder, chairman and chief executive officer Stephen P.A. Fodor said in the release.

The 1 million-SNP product, which is scheduled to be available to a limited number of customers in the first quarter of 2007, is expected to sell for around $500.

Affymetrix is a biopharmaceutical company with headquarters in Santa Clara, Calif.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.